THC also has a consistent suppressive effect on NF‐kB, AP‐1, and pro‐inflammatory mediators, which may explain its particular utility in inflammation‐driven malignancies such as colon, gastric, and breast cancers, where it could be considered an adjuvant treatment (Xu et al. 2018; Lai et al. 2020). Here, NFKB1 is linked to breast carcinoma.